Kurs
+5,31%
Likviditet
0,96 MSEK
Prenumeration
Kalender
Est. tid* | ||
2025-11-07 | 08:30 | Kvartalsrapport 2025-Q3 |
2025-08-27 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-05-20 | N/A | X-dag ordinarie utdelning SEZI 0.00 SEK |
2025-05-19 | N/A | Årsstämma |
2025-04-22 | - | Kvartalsrapport 2025-Q1 |
2025-02-17 | - | Bokslutskommuniké 2024 |
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-10-23 | - | Extra Bolagsstämma 2024 |
2024-08-26 | - | Kvartalsrapport 2024-Q2 |
2024-05-17 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2024-05-16 | - | Årsstämma |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-28 | - | Extra Bolagsstämma 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-17 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2023-05-16 | - | Årsstämma |
2023-04-28 | - | Kvartalsrapport 2023-Q1 |
2023-02-20 | - | Bokslutskommuniké 2022 |
2023-02-16 | - | Extra Bolagsstämma 2022 |
2022-11-10 | - | Kvartalsrapport 2022-Q3 |
2022-07-15 | - | Kvartalsrapport 2022-Q2 |
2022-05-19 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2022-05-18 | - | Årsstämma |
2022-05-05 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-11-12 | - | Kvartalsrapport 2021-Q3 |
2021-08-27 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2021-05-11 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-03-05 | - | Extra Bolagsstämma 2021 |
2021-02-26 | - | Bokslutskommuniké 2020 |
2020-11-06 | - | Kvartalsrapport 2020-Q3 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-07-02 | - | Extra Bolagsstämma 2020 |
2020-05-15 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2020-05-14 | - | Årsstämma |
2020-05-08 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-08 | - | Kvartalsrapport 2019-Q3 |
2019-08-22 | - | Kvartalsrapport 2019-Q2 |
2019-08-21 | - | Extra Bolagsstämma 2019 |
2019-05-09 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2019-05-08 | - | Årsstämma |
2019-05-08 | - | Kvartalsrapport 2019-Q1 |
2019-02-15 | - | Bokslutskommuniké 2018 |
2018-11-08 | - | Kvartalsrapport 2018-Q3 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-05-09 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2018-05-08 | - | Årsstämma |
2018-05-08 | - | Kvartalsrapport 2018-Q1 |
2018-03-05 | - | Extra Bolagsstämma 2018 |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-11-28 | - | Kvartalsrapport 2017-Q3 |
2017-09-15 | - | Extra Bolagsstämma 2017 |
2017-08-31 | - | Kvartalsrapport 2017-Q2 |
2017-05-23 | - | Årsstämma |
2017-05-23 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-11-22 | - | Kvartalsrapport 2016-Q3 |
2016-08-31 | - | Kvartalsrapport 2016-Q2 |
2016-05-17 | - | Extra Bolagsstämma 2016 |
2016-04-28 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2016-04-27 | - | Årsstämma |
2016-04-27 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-11-24 | - | Kvartalsrapport 2015-Q3 |
2015-08-26 | - | Kvartalsrapport 2015-Q2 |
2015-05-20 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2015-05-19 | - | Årsstämma |
2015-05-19 | - | Kvartalsrapport 2015-Q1 |
2015-02-25 | - | Bokslutskommuniké 2014 |
2014-11-27 | - | Kvartalsrapport 2014-Q3 |
2014-11-21 | - | Extra Bolagsstämma 2014 |
2014-08-21 | - | Kvartalsrapport 2014-Q2 |
2014-05-15 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2014-05-14 | - | Årsstämma |
2014-05-14 | - | Kvartalsrapport 2014-Q1 |
2014-02-24 | - | Bokslutskommuniké 2013 |
2013-11-27 | - | Kvartalsrapport 2013-Q3 |
2013-08-20 | - | Kvartalsrapport 2013-Q2 |
2013-05-16 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2013-05-15 | - | Årsstämma |
2013-05-15 | - | Kvartalsrapport 2013-Q1 |
2013-02-28 | - | Bokslutskommuniké 2012 |
2013-01-08 | - | Extra Bolagsstämma 2013 |
2012-11-21 | - | Kvartalsrapport 2012-Q3 |
2012-08-21 | - | Kvartalsrapport 2012-Q2 |
2012-05-24 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2012-05-23 | - | Årsstämma |
2012-05-23 | - | Kvartalsrapport 2012-Q1 |
2012-02-22 | - | Bokslutskommuniké 2011 |
2011-11-23 | - | Kvartalsrapport 2011-Q3 |
2011-08-23 | - | Kvartalsrapport 2011-Q2 |
2011-05-27 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2011-05-26 | - | Årsstämma |
2011-05-26 | - | Kvartalsrapport 2011-Q1 |
2011-02-16 | - | Bokslutskommuniké 2010 |
2010-11-24 | - | Kvartalsrapport 2010-Q3 |
2010-05-28 | - | X-dag ordinarie utdelning SEZI 0.00 SEK |
2010-05-27 | - | Kvartalsrapport 2010-Q1 |
2009-11-25 | - | Kvartalsrapport 2009-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
News: Uppsala, August 5, 2022. Senzime announces today the launch of TetraGraph® Xcom, a solution that enables communication between the TetraGraph® and Philips Capsule Medical Device Information Platform (MDIP). The integration enables the electronic transmission of neuromuscular data from the TetraGraph® directly to the patient's medical record.
Philips Capsule is a leading global provider of medical device integration and information solutions for healthcare providers. Founded more than two decades ago and with over 2,700 hospital sites and 20 million patients connected annually, Philips Capsule is the standard for medical device integration and is expanding the boundaries of system interoperability, patient monitoring, and clinical surveillance.
Senzime’s TetraGraph® system helps anesthesia providers improve patient care, eliminate complications, and reduce healthcare costs by digitally and continuously measure the degree of neuromuscular blockade under and after surgery.
The new TetraGraph® Xcom interface and the Philips Capsule Medical Device Information Platform (MDIP) connects almost all existing medical devices and EMRs in hospitals through a vendor-neutral system and is designed to help improve workflow and save time. Interconnected medical devices are essential resources in the delivery of patient care.
Pia Renaudin, CEO of Senzime states, " With our new Xcom interface the TetraGraph® can transmit critical patient information and displayed it on a wide range of EMR- and EHR-systems worldwide. Our smart new connector and partnership with Philips Capusle enables healthcare providers to standardize the monitoring of patients with paralytic drugs using the Senzime TetraGraph® system.”
This interface is in line with Senzime’s vision to standardize patient monitoring with the TetraGraph®-system when neuromuscular blocking drugs are used.
For further information, please contact:
Pia Renaudin, CEO of Senzime AB
Phone: +46 (0) 70-813 34 17, email: pia.renaudin@senzime.com
About Senzime
Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications. The company markets an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.
Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world’s leading markets. The company’s shares are listed on Nasdaq Stockholm Main Market (SEZI). www.senzime.com